Deepak 34D00110113059

PATIENT ID
PATIENT NAME
: 34D00110113059
34D00110113059
AGE/SEX
HINDLABS WASHIM
: DEEPAK KAMBLE : 22Y/MALE

REF. BY DOCTOR : District Hospital, Washim. REG. DATE/TIME : 19/12/2023 01:56 pm
FACILITY NAME : District Hospital, Washim REPORT DATE/TIME : 19/12/2023 04:22 pm
CLIENT NAME : NHM
BIOCHEMISTRY
Investigation Result Units Biological Reference Interval
Serum Blood Urea 22.18 mg/dL 10 - 50
• Sample Type : Serum.
• Method : UREASE/GLDH methodology.
BUN-Blood Urea Nitrogen 10.35806 mg/dl 6 - 20
• Method: BUN is calculated.
Glycosylated Haemoglobin(HBA1C) 5.7 % Below 5.7 % : Non - diabetic
5.7 - 6.4 % : Pre Diabetic
>= 6.5 : Diabetic
8.0 - 10.0 % : Unsatisfactory
> 10 % : Poor Control
• Sample Type : EDTA.
• Method : H.P.L.C.
Mean Blood Glucose 116.89 mg/dl
• Method : Calculated from HBA1C Values.
• Please correlate with clinical conditions.
*References from :ADA(american diabetes association 2010).
Serum Calcium 8.8 mg/dL 8.8 - 10.2
• Method: Arsenazo III Method, End point.
Serum Uric Acid 3.6 mg/dL 3.5 - 7.2
• Method: Uricase-PAP Method
Serum Creatinine 1 mg/dL 0.9 - 1.3
• Method : Modified Jaffes Method.
PROCESSED AT HINDLABS WASHIM Dr. Kishor Lonkar

M.D., Path
Patient Registration Code : 1723503633

Page 1 of 4
PATIENT ID
PATIENT NAME
: 34D00110113059
34D00110113059
AGE/SEX
HINDLABS WASHIM

CLIENT NAME : NHM
BIOCHEMISTRY
Serum Bilirubin, Total 0.75 mg/dL 0 - 1.2

• Method : Modified TAB method.
Serum Bilirubin, Direct 0.09 mg/dL 0 - 0.4
• Sample Type: Serum.
• Method: Diazo.
Serum Bilirubin, Indirect 0.66 mg/dl 0.2 - 0.9
• Method: BILI-Calculated-(from serum total and Direct Bilirubin value by Diazo method).
Serum Bilirubin, Direct 0.09 mg/dL 0 - 0.4
• Method: Diazo.
Serum SGOT 16.65 U/L 0 - 46
• Method : IFCC WITHOUT PYRIDOXAL PHOSPHATE.
Serum SGPT 18.56 U/L 0 - 49
• Method : IFCC WITHOUT PYRIDOXAL PHOSPHATE.
Serum Total Protein 6.7 g/dL 6-8
• Method: Direct Biuret Method.
Serum Albumin 4.13 g/dL 3.5 - 5.2
• Method: BROMOCRESOL GREEN METHOD.
Serum Globulin 2.57 gm/dl 2.5 - 3.5
• Method: Calculated.
• Interpretation :
1) HBA1C is used for monitoring Diabetic control. It reflects the estimated average glucose (e AG).
2) HBA1C has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines 2018
for diagnosis of Low glycated hemoglobin (below 4%) in a Non-Diabetic individual are often associated
with systemic inflammatory diseases.
• Note :
HB F higher than 10 % of total Hb may yield falsely low results. Conditions that shorten red cell survival,
such as presence of unstable hemoglobin like Hb, CC and Hb SC Or the causes of hemolytic Anemia. May yield
falsely low result. Iron deficiency anemia may yield falsely high results.
PROCESSED AT HINDLABS WASHIM --End Of Report-- Dr. Kishor Lonkar

M.D., Path

Page 2 of 4
PATIENT ID
PATIENT NAME
: 34D00110113059
34D00110113059
AGE/SEX
HINDLABS WASHIM

CLIENT NAME : NHM
COMPLETE BLOOD COUNT

Hemoglobin (Hb) 13.5 gm/dl 13.0 - 17.0
Total RBC Count 5.06 Millions/Cumm 4.5 - 5.5
PCV 42.1 % 40 - 50
MCV 83.1 fL 83 - 101
MCH 26.7 Pg 27 - 32
MCHC 32.2 g/dL 31.5 - 34.5
RDW-CV 14.5 % 11.6 - 14.0
Total Leucocyte Count(TLC) 6650 Cells/Cumm 4000 - 10000
DIFFERENTIAL COUNT
Polymorphs 58 % 40 - 80
Lymphocytes 31 % 20 - 40
Monocytes 04 % 2 - 10
Eosinophils 07 % 1-6
Basophils 00 % 0-2
Platelet Count 3.74 Lakhs/Cumm 1.5 - 4.1
• Sample Type: EDTA Whole Blood.

• Method: Fully automated Hematology analyzer.
• HB: Spectrophotometry, Total RBC Count: Impedence, PCV/HCT,MCV,MCH,MCHC,RDW-CV: Calculated.WBC:Impedence.
• Monocyte,Neutrocyte,Lymphocyte,Basophills,Eosinophills: Flow Cytometry.Platelet: Impedence.
--End Of Report--

M.D., Path

Page 3 of 4
PATIENT ID
PATIENT NAME
: 34D00110113059
34D00110113059
AGE/SEX
HINDLABS WASHIM

CLIENT NAME : NHM
IMMUNOASSAY
Serum T3 1.01 ng/mL 0.8 - 1.9
Sample Type: Serum.

Method: CLIA Microparticles.
Serum T4 8.06 µg/dl 5 - 13
Sample Type: Serum.
Method: CLIA Microparticles
Serum TSH 2.5 µIU/ml 0.35 - 5.5

• Method: CLIA Microparticles.
Interpretation:
1) In pregnancy there is an alteration in thyroid hormone production and metabolism.
2) Useful for screening of thyroid illness, primary/secondary hypo-or hyperthyroidism, and also for monitoring patients with thyroid replacement therapy. •
Please correlate with clinical conditions.
*References from Wallach’s Interpretation of Diagnostic Tests. (10th edition).
--End Of Report--

M.D., Path

Page 4 of 4

Deepak 34D00110113059

Uploaded by

Copyright:

Available Formats

Deepak 34D00110113059

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Deepak 34D00110113059

Uploaded by

Copyright:

Available Formats

PATIENT ID

: DEEPAK KAMBLE : 22Y/MALE

PROCESSED AT HINDLABS WASHIM Dr. Kishor Lonkar

Patient Registration Code : 1723503633

: DEEPAK KAMBLE : 22Y/MALE

Serum Bilirubin, Total 0.75 mg/dL 0 - 1.2

PROCESSED AT HINDLABS WASHIM --End Of Report-- Dr. Kishor Lonkar

Patient Registration Code : 1723503633

: DEEPAK KAMBLE : 22Y/MALE

COMPLETE BLOOD COUNT

• Sample Type: EDTA Whole Blood.

PROCESSED AT HINDLABS WASHIM Dr. Kishor Lonkar

Patient Registration Code : 1723503633

: DEEPAK KAMBLE : 22Y/MALE

Sample Type: Serum.

• Sample Type: Serum.

*References from Wallach’s Interpretation of Diagnostic Tests. (10th edition).

PROCESSED AT HINDLABS WASHIM Dr. Kishor Lonkar

Patient Registration Code : 1723503633

You might also like